Method of Determining Response to Treatment with Immunomodulatory Composition

The present invention provides a method for accurately determining the likelihood that a subject will respond to treatment with an immunomodulatory composition comprising detecting one or more markers in a sample from the subject, wherein at least one markers is linked to a single nucleotide polymorphism (SNP) set forth in Table 1 or 3-5, and processes for selecting suitable subjects for therapy or for continued therapy, and for providing appropriate therapy to subjects, based on the assay results.

Patents:
WO 2,010,144,946

Inventor(s): GEORGE JACOB [AU]; BOOTH DAVID [AU]; SUPPIAH VIJAYAPRAKASH [AU]; STEWART GRAEME [AU]

Type of Offer: Sale



Next Patent »
« More Medical Patents

Share on      


CrowdSell Your Patent